Related Experiment Video
Updated: Jun 13, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Dilated cardiomyopathy in epidermolysis bullosa
Irene Lara-Corrales1, Elena Pope
1The Hospital for Sick Children, Toronto, ON, Canada.
Insights
Dilated cardiomyopathy (DC) is a serious complication of epidermolysis bullosa. Early detection and treatment of DC in epidermolysis bullosa patients can improve outcomes and survival rates.
Area of Science:
- Cardiology
- Genetics
- Dermatology
Background:
- Dilated cardiomyopathy (DC) is a rare, life-threatening condition.
- Epidermolysis bullosa (EB) is a group of rare genetic connective tissue disorders.
- DC is a known complication of EB, but its causes are not fully understood.
Purpose of the Study:
- To review the potential causes and contributing factors of DC in EB patients.
- To emphasize the importance of early detection and management of DC in EB.
- To highlight the impact of medical interventions on disease progression and survival.
Main Methods:
- Literature review of reported cases of DC in EB.
- Analysis of proposed etiological factors for DC in this population.
- Discussion of current diagnostic and therapeutic strategies.
Main Results:
- Several factors are implicated in DC development in EB, including iron overload, carnitine deficiency, selenium deficiency, viral infections, anemia, and certain medications.
- No single cause is definitively identified, suggesting multifactorial etiology.
- Early diagnosis and treatment are crucial.
Conclusions:
- DC is a significant concern in epidermolysis bullosa management.
- Multifactorial etiologies necessitate a comprehensive approach to diagnosis and treatment.
- Prompt medical intervention can significantly alter the clinical course and prognosis of DC in EB patients.
Abstract:
Dilated cardiomyopathy (DC) is a rare but potentially fatal complication of epidermolysis bullosa. No clear cause for it has been identified, but iron overload, low carnitine, low selenium, concomitant viral illness, chronic anemia, and medications have been proposed as possible contributors to the development of DC in reported cases. Early detection allows for medical treatment that delays clinical progression and prolongs survival.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Desmosomes
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease I: Introduction

